Yuan Ji

1993–2026 年に発表

別表記
Yu'an Ji
369
論文数
28,184
被引用数
85
h 指数
288
i10 指数

被引用数

Yuan Ji の年別被引用数1982 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 34 件1995 年: 被引用 92 件1996 年: 被引用 138 件1997 年: 被引用 166 件1998 年: 被引用 114 件1999 年: 被引用 90 件2000 年: 被引用 70 件2001 年: 被引用 41 件2002 年: 被引用 37 件2003 年: 被引用 25 件2004 年: 被引用 21 件2005 年: 被引用 41 件2006 年: 被引用 49 件2007 年: 被引用 40 件2008 年: 被引用 60 件2009 年: 被引用 70 件2010 年: 被引用 94 件2011 年: 被引用 95 件2012 年: 被引用 97 件2013 年: 被引用 123 件2014 年: 被引用 127 件2015 年: 被引用 111 件2016 年: 被引用 175 件2017 年: 被引用 227 件2018 年: 被引用 265 件2019 年: 被引用 741 件2020 年: 被引用 1,010 件2021 年: 被引用 1,115 件2022 年: 被引用 1,036 件2023 年: 被引用 922 件2024 年: 被引用 1,811 件2025 年: 被引用 993 件2026 年: 被引用 64 件1983〜1984 年は被引用が無いため表示していません1987〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,575 件、この内訳の 25.1%アメリカ合衆国: 引用元論文 3,195 件、この内訳の 22.5%イギリス: 引用元論文 710 件、この内訳の 5%ドイツ: 引用元論文 615 件、この内訳の 4.3%イタリア: 引用元論文 514 件、この内訳の 3.6%カナダ: 引用元論文 489 件、この内訳の 3.4%日本: 引用元論文 389 件、この内訳の 2.7%フランス: 引用元論文 310 件、この内訳の 2.2%オーストラリア: 引用元論文 307 件、この内訳の 2.2%スペイン: 引用元論文 298 件、この内訳の 2.1%オランダ: 引用元論文 265 件、この内訳の 1.9%韓国: 引用元論文 259 件、この内訳の 1.8%
0%25.1%その他 23.2%

分野

  • Medicine41.8%
  • Biochemistry, Genetics and Molecular Biology35.1%
  • Pharmacology, Toxicology and Pharmaceutics3.8%
  • Computer Science3.8%
  • Engineering3.4%
  • Immunology and Microbiology3%
  • その他9.1%

トピック

  • Hepatocellular Carcinoma Treatment and Prognosis3.6%
  • Cancer Genomics and Diagnostics3.2%
  • Radiomics and Machine Learning in Medical Imaging2.4%
  • Cell death mechanisms and regulation2.4%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.2%
  • Cancer Immunotherapy and Biomarkers1.8%
  • その他84.4%

共著者

全論文

検索で開く
  1. The evolutionary history of 2,658 cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David D.L. Bowtell, Hongtu Zhu, Gad Getz, Marcin Imieliński, Rameen Beroukhim, S. Cenk Şahinalp, Yuan Ji, Martin Peifer, Florian Markowetz, Ville Mustonen, Ke Yuan, Wenyi Wang, Quaid D. Morris, PCAWG Evolution & Heterogeneity Working Group, Stefan C. Dentro, Ignaty Leshchiner, Moritz Gerstung, Clemency Jolly, Kerstin Haase, Maxime Tarabichi, Jeff Wintersinger, Amit G. Deshwar, Kaixian Yu, Santiago Gonzalez, Yulia Rubanova, Geoff Macintyre, David J. Adams, Pavana Anur, Rameen Beroukhim, Paul C. Boutros, David D.L. Bowtell, Peter J. Campbell, Shaolong Cao, Elizabeth L. Christie, Marek Cmero, Yupeng Cun, Kevin J. Dawson, Jonas Demeulemeester, Nilgun Donmez, Ruben M. Drews, Roland Eils, Yu Fan, Matthew W. Fittall, Dale W. Garsed, Gad Getz, Gavin Ha, Marcin Imieliński, Lara Jerman, Yuan Ji, Kortine Kleinheinz, Juhee Lee, Henry Lee-Six, Dimitri Livitz, Salem Malikić, Florian Markowetz, Iñigo Martincorena, Thomas J. Mitchell, Ville Mustonen, Layla Oesper, Martin Peifer, Myron Peto, Benjamin J. Raphael, Daniel Rosebrock, S. Cenk Şahinalp, Adriana Salcedo, Matthias Schlesner, Steven E. Schumacher, Subhajit Sengupta, Ruian Shi, Seung Jun Shin ほか 1,341 名 - Nature, Nat. 2020 被引用: 1,141

  2. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baojin Hua, Xiaowu Huang, Weidong Jia, Yaming Li, Ye‐Xiong Li, Jun Liang, Tianshu Liu, Guoyue Lv, Yilei Mao, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Kaishan Tao, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Jianyong Yang, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhengyu Yin, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yongfu Zhao, Honggang Zheng, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jianqiang Cai, Weilin Wang, Xiujun Cai, Qiang Li, Feng Shen, Shukui Qin, Jiahong Dong, Jia Fan - Liver Cancer 2020 被引用: 833

  3. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas McGranahan, Charles Swanton, Gad Getz, Paul C. Boutros, Marcin Imieliński, Rameen Beroukhim, S. Cenk Şahinalp, Yuan Ji, Martin Peifer, Iñigo Martincorena, Florian Markowetz, Ville Mustonen, Ke Yuan, Moritz Gerstung, Paul T. Spellman, Wenyi Wang, Quaid Morris, David C. Wedge, Peter Van Loo, Stefan C. Dentro, Ignaty Leshchiner, Moritz Gerstung, Clemency Jolly, Kerstin Haase, Maxime Tarabichi, Jeff Wintersinger, Amit G. Deshwar, Kaixian Yu, Santiago González, Yulia Rubanova, Geoff Macintyre, Jonas Demeulemeester, David J. Adams, Pavana Anur, Rameen Beroukhim, Paul C. Boutros, David D.L. Bowtell, Peter J. Campbell, Shaolong Cao, Elizabeth L. Christie, Marek Cmero, Yupeng Cun, Kevin J. Dawson, Nilgun Donmez, Ruben M. Drews, Roland Eils, Yu Fan, Matthew W. Fittall, Dale W. Garsed, Gad Getz, Gavin Ha, Marcin Imieliński, Lara Jerman, Yuan Ji, Kortine Kleinheinz, Juhee Lee, Henry Lee-Six, Dimitri Livitz, Salem Malikić, Florian Markowetz, Iñigo Martincorena, Thomas J. Mitchell, Ville Mustonen, Layla Oesper, Martin Peifer, Myron Peto, Benjamin J. Raphael, Daniel Rosebrock, S. Cenk Şahinalp, Adriana Salcedo ほか 19 名 - Cell 2021 被引用: 571

  4. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shuqun Cheng, Chaoliu Dai, Wenzhi Guo, Yabing Guo, Baojin Hua, Xiaowu Huang, Weidong Jia, Qiu Li, Tao Li, Xun Li, Yaming Li, Ye‐Xiong Li, Jun Liang, Changquan Ling, Tianshu Liu, Xiufeng Liu, Shichun Lu, Guoyue Lv, Yilei Mao, Zhiqiang Meng, Tao Peng, Weixin Ren, Hongcheng Shi, Guo‐Ming Shi, Ming Shi, Tianqiang Song, Kaishan Tao, Jianhua Wang, Kui Wang, Lu Wang, Wentao Wang, Xiaoying Wang, Zhiming Wang, Bang‐De Xiang, Baocai Xing, Jianming Xu, Jiamei Yang, Yang Jianyong, Yefa Yang, Yunke Yang, Sheng‐Long Ye, Zhen‐Yu Yin, Yong Zeng, Bixiang Zhang, Boheng Zhang, Leida Zhang, Shuijun Zhang, Ti Zhang, Yanqiao Zhang, Ming Zhao, Yongfu Zhao, Honggang Zheng, Ledu Zhou, Jiye Zhu, Kangshun Zhu, Rong Liu, Ying–Hong Shi, Yong‐Sheng Xiao, Lan Zhang, Chun Yang, Zhifeng Wu, Zhi Dai, Minshan Chen, Jianqiang Cai, Weilin Wang, Xiujun Cai, Q. Li, Feng Shen, Shukui Qin, Gao‐Jun Teng ほか 2 名 - Liver Cancer 2023 被引用: 452

  5. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haixiang Sun, Na Yao, Xiangyu Zhang, Shiyu Zhang, Xi Chen, Yang Yu, Yao Li, Fengming Liu, Zheng Wang, Shao‐Lai Zhou, Huanming Yang, Shuang Yang, Xun Xu, Longqi Liu, Qiang Gao, Zhao–You Tang, Xiangdong Wang, Jian Wang, Jia Fan, Shiping Liu, Xin‐Rong Yang, Ao Chen, Jian Zhou, Ao Chen, Jian Zhou - Cell Research 2023 被引用: 218

  6. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 246

  7. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yong Hou, Jia Fan, Xin‐Rong Yang - Nature Communications 2021 被引用: 215

  8. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jian Zhou, Xingxu Huang, David H. Peng, Liye Zhang, Jia Fan - Cancer Cell 2023 被引用: 109

  9. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

    著者: , , , , , , , , , , , , , , - Liver Cancer 2021 被引用: 237

  10. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

    著者: , , , , , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2015 被引用: 975

  11. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan - HepatoBiliary Surgery and Nutrition 2022 被引用: 198

  12. Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 154

  13. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guoyue Lv, Yi-Lei Mao, Wei-Xin Ren, Hong-Cheng Shi, Wen-Tao Wang, Xiaoying Wang, Bao-Cai Xing, Jian-Ming Xu, Jian-Yong Yang, Ye-Fa Yang, Sheng-Long Ye, Zheng-Yu Yin, Bo-Heng Zhang, Shui-jun Zhang, Wei-Ping Zhou, Ji-Ye Zhu, Rong Liu, Ying-Hong Shi, Yong-Sheng Xiao, Zhi Dai, Gao‐Jun Teng, Jian-qiang Cai, Wei–Lin Wang, Jiahong Dong, Qiang Li, Feng Shen, Shu-Kui Qin, Jia Fan - Liver Cancer 2018 被引用: 688

  14. Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2023 被引用: 148

  15. Distributed Finite-Time Safety Consensus Control of Vehicle Platoon With Senor and Actuator Failures

    著者: , , , , , - IEEE Transactions on Vehicular Technology, IEEE Trans. Veh. Technol. 2022 被引用: 62

  16. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes

    著者: , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2019 被引用: 161

  17. Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma

    著者: , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 被引用: 60

  18. Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 被引用: 255

  19. A Pharmacogenomic Landscape in Human Liver Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Haibin Zhang, Yixue Li, Lijian Hui - Cancer Cell 2019 被引用: 218

  20. Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

    著者: , , , , , , , , , , , , , , - Annals of Surgical Oncology 2022 被引用: 72

  21. A 3D culture system improves the yield of MSCs-derived extracellular vesicles and enhances their therapeutic efficacy for heart repair

    著者: , , , , , , , , , , , , , - Biomedicine & Pharmacotherapy 2023 被引用: 52

  22. Recommendations for Clinical CYP2D6 Genotyping Allele Selection

    著者: , , , , , , , , , , , , - Journal of Molecular Diagnostics 2021 被引用: 154

  23. The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 84

  24. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme

    著者: - Cell 1993 被引用: 2,491